IRX3 and obesity due to melanocortin 4 receptor deficiency: Thus, IRX3 has been suggested as a functional long-range target of obesity-associated variants within FTO and represents a novel determinant of body mass and composition, by regulating the process of thermogenesis as they can prevent the process in which energy is turned into heat, thus stored as fat [3, 4].